Sunitinib for imatinib-resistant GIST

Lancet. 2006 Oct 14;368(9544):1303-4. doi: 10.1016/S0140-6736(06)69489-0.
No abstract available

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / enzymology
  • Gastrointestinal Stromal Tumors / pathology
  • Humans
  • Imatinib Mesylate
  • Indoles / pharmacology
  • Indoles / therapeutic use*
  • Liver Neoplasms / secondary
  • Multicenter Studies as Topic
  • Piperazines / pharmacology
  • Piperazines / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use*
  • Pyrroles / pharmacology
  • Pyrroles / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Sunitinib

Substances

  • Antineoplastic Agents
  • Benzamides
  • Indoles
  • Piperazines
  • Pyrimidines
  • Pyrroles
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Sunitinib